TITLE

Pulmonary Zygomycosis in a Diabetic Patient: Treated with Pneumonectomy and Antifungal Agents

AUTHOR(S)
MAHMOOD, AHMED; CHAUMP, MICHAEL; KNOLL, BETTINA; ASWAD, BASSAM
PUB. DATE
September 2014
SOURCE
Rhode Island Medical Journal;Sep2014, Vol. 97 Issue 9, p44
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
110406888

 

Related Articles

  • Treatment of zygomycosis: current and new options.  // Journal of Antimicrobial Chemotherapy (JAC);Jan2008, Vol. 61, pi35 

    Zygomycosis is a frequently lethal invasive infection in high-risk patients such as the immunocompromised [especially haematopoietic stem cell transplant (HSCT) recipients] and patients with type 2 diabetes mellitus. However, zygomycosis has also been reported in individuals without known risk...

  • Immunosuppressants/caspofungin/fluconazole.  // Reactions Weekly;1/29/2011, Issue 1336, p26 

    The article describes the case of a 16-year-old man multiple organ transplant recipient who developed zygomycosis while receiving therapy with immunosuppressive and antifungal agents. The patient presented with diarrhea, neutropenia and lymphopenia. Amphotencin B and posaconazole treatment was...

  • Zygomicosis rinosinusal-orbital. Falla terapéutica con anfotericina y respuesta con posaconazol. reporte de un caso y revisión de la bibliografía. Hernández, Víctor Cruz; Tapia, Samuel León; Ibáñez, Gabriela Barragán; López, Omar Martínez // Medicina Interna de Mexico;sep/oct2012, Vol. 28 Issue 5, p508 

    The zygomycosis widely known as mucormycosis, a rare fungal infection that occurs in immunocompromised patients, such as diabetic ketoacidosis, patients with chemotherapy, immunosuppressive therapy in autoimmune diseases. The site of involvement may be rhinosinusal / rhinocerebral, pulmonary,...

  • Invasive zygomycosis in India: experience in a tertiary care hospital. A Chakrabarti // Postgraduate Medical Journal;Nov2009, Vol. 85 Issue 1009, p573 

    AIM: To report the natural history and clinical course of zygomycosis from a single tertiary care centre in India where doctors maintain an institutional zygomycosis registry. METHODS: The clinical and laboratory data collected prospectively from patients with antemortem diagnosis for invasive...

  • Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole. Kleinotiene, Grazina; Posiunas, Gintas; Raistenskis, Juozas; Zurauskas, Edvardas; Stankeviciene, Sigita; Daugelaviciene, Valentina; Machaczka, Maciej // Medical Oncology;Mar2013, Vol. 30 Issue 1, p1 

    Pulmonary zygomycosis, also referred to as mucormycosis, is a fungal infection of lungs caused by fungi of the order Mucorales in the class of Zygomycetes. It is usually associated with high morbidity and mortality. Here, we report the case of a 14-year-old girl with pediatric acute...

  • Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases. Roden, Maureen M.; Zaoutis, Theoklis E.; Buchanan, Wendy L.; Knudsen, Lena A.; Sarkisova, Tatyana A.; Schaufele, Robert L.; Sein, Michael; Sein, Tin; Chiou, Christine C.; Chu, Jaclyn H.; Kontoyiannis, Dimitrios P.; Walsh, Thomas J. // Clinical Infectious Diseases;9/1/2005, Vol. 41 Issue 5, p634 

    Background. Zygomycosis is an increasingly emerging life-threatening infection. There is no single comprehensive literature review that describes the epidemiology and outcome of this disease. Methods. We reviewed reports of zygomycosis in the English-language literature since 1885 and analyzed...

  • Itraconazole in chronic pulmonary aspergillosis: In whom, for how long, and at what dose? Maturu, Venkata Nagarjuna; Agarwal, Ritesh // Lung India;Jul/Aug2015, Vol. 32 Issue 4, p309 

    The authors discuss a study related to use of antifungal agent itraconazole for treating pulmonary aspergillosis caused by fungus Aspergillus fumigatus published within the periodical. Topics discussed include symptoms of chronic necrotizing pulmonary aspergillosis such as hemoptysis and reasons...

  • Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. Ritz, Nicole; Ammann, Roland A.; Aebischer, Carmen Casaulta; Gugger, Mathias; Jaton, Katia; Schmid, Ralph A.; Aebi, Christoph // European Journal of Pediatrics;Apr2005, Vol. 164 Issue 4, p231 

    Unlabelled: Voriconazole is increasingly used as a first-line agent for empirical antifungal therapy of prolonged febrile neutropenia in paediatric cancer patients. We describe the case of a 9-year-old patient with stage IV Burkitt lymphoma, who developed pulmonary and splenic...

  • Voriconazole.  // Reactions Weekly;5/6/2006, Issue 1100, p23 

    Presents the study "Pulmonary Zygomycosis in a Patient Treated for Invasive Aspergillosis," which appeared in the February 2006 issue of "Medecine et Maladies Infectieuses." Background on the patient.

  • Zygomycosis Caused by Rhizopus microsporus and Rhizopus oryzae in Madhya Pradesh (M.P.) Central India: A Report of Two Cases. Nawange, Shesh; Singh, S.; Naidu, J.; Jain, S.; Nagpal, T.; Behrani, D.; Mellado, E.; Tudela, J. // Mycopathologia;Aug2012, Vol. 174 Issue 2, p171 

    Zygomycosis encompasses infections due to two distinct orders of fungi, Mucorales and Entomophthorales. With rare exception, Entomophthorales are restricted to tropical areas. By contrast, mucorales are ubiquitous opportunistic fungi, which play a crucial part in the natural decay process. In...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics